CanQuest interview with Stock Day Podcast - NOv 25, 2019
The original release is unavailable here.
CanaQuest Medical Corporation on 6ix
Earlier from CanaQuest Medical
- CANAQUEST MEDICAL CORP is the Winner of the Go Global Awards "Business of the Year – Category of Life Science” presented by the International Trade Council
- CanaQuest has developed a safer THC medical cannabis formulation (Metabinol™) from research and pre-clinical trials at Western University, London, Ontario, Canada
- CANAQUEST MEDICAL CORP announces filing of INTERNATIONAL CANNABIS PATENT
- CANAQUEST MEDICAL CORP announces Award of a Cannabis Purchase/Sales Licence as permitted under the Health Canada Cannabis Act, through its wholly owned subsidiary, ADC BioMedical Corp.
- CANAQUEST MEDICAL CORP has been selected as a Global Awards Finalist by the International Trade Council
Later from CanaQuest Medical
- Canaquest Medical Corp Awaits Health Canada Approval for Sales and Export of Mentabinol®
- CanaQuest Medical corp files provisional Patent for Mentanine® - omega-3 & pure cannabidiol (“CBD”) formulation boosting mental health efficacy while minimizing CBD dosage
- OCMX Listing
- CanaQuest Medical corp secures approval for listing on the OCMX™, an online investor and financial connection portal
- CanaQuest announces Mentabinol® a scientific discovery, as published in The Journal of Neuroscience
Follow CanaQuest Medical into a list and get an email when it puts out news.
Follow CanaQuest Medical